Breckenridge Pharmaceutical, Inc. recalls Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical,
Recalled November 21, 2018 · FDA recall D-0279-2019 · Breckenridge Pharmaceutical
Hazard
Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing. · FDA Class III
Units
9,193 bottles
Sold at
Nationwide within the United States
Description
Failed Stability Specifications: Out-of-Specification results obtained for particle size distribution during stability testing.
Product
Megestrol Acetate Oral Suspension, USP 625 mg/5mL, 150 mL bottle, Rx only, Distributed by: Breckenridge Pharmaceutical, Inc. Boca Raton, FL 33487, Manufactured by: Pharmaceutics International Inc. Hunt Valley, MD 21031
Manufacturer(s)
Breckenridge Pharmaceutical, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →